LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid Test Kit Detects Dengue Antibodies in Saliva

By LabMedica International staff writers
Posted on 09 Feb 2015
Image: A three dimensional model of the rapid test kit that detects dengue-specific antibodies (Photo courtesy of the Agency for Science, Technology and Research, A*STAR).
Image: A three dimensional model of the rapid test kit that detects dengue-specific antibodies (Photo courtesy of the Agency for Science, Technology and Research, A*STAR).
A paper-based disposable device has been developed that will allow dengue-specific antibodies to be detected easily from saliva within 20 minutes and the device is currently undergoing further development.

Paper-based immunoassays, usually in the form of lateral flow tests, are currently the standard platform for home diagnostics. However, conventional lateral tests are often complicated by severe nonspecific adsorption of detector particles when applied to test samples containing salivary fluid.

Scientists at the Institute of Bioengineering and Nanotechnology (The Nanos; Singapore) developed a stacking flow device consisting of a test strip, a sample pad, a reagent pad, an absorbent pad, and a flow regulator. The sample and reagent pads were made of glass fiber, and the absorbent pad was made of cellulose (Merck Millipore, Billerica, Massachusetts, USA). The nitrocellulose test strip was cut into the required dimensions manually with a roller cutter. The detection of dengue-specific immunoglobulin G (IgG) was conducted using the liquid conjugate approach. The liquid conjugate was composed of protein G-conjugated 40 nm gold nanoparticles.

In the device, different flow paths are created for samples and reagents through a multiple stacked system. This allows the saliva sample to flow separately through a fiber glass matrix, which removes the substances that would interfere with the nanoparticle-based sensing system before it mixes with the sensor nanoparticles. The device’s configuration also helps to regulate the flow in the test strip, generating uniform test lines for more accurate results. The stacking flow immunoassay platform requires only one user activation step: both the sample and reagents are added at the same time in a single step. Both the sample and reagents react and flow concurrently in the test strip. The single-step procedure significantly improved the ease of usage of the test kit. The study was published on January 12, 2015, in the journal Lab on a Chip.

Related Links:

Institute of Bioengineering and Nanotechnology
Merck Millipore  


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more